Tumor-infiltrating lymphocytes predict prognosis of breast cancer patients treated with anti-Her-2 therapy-Reference-Cited by-同舟云学术

Tumor-infiltrating lymphocytes predict prognosis of breast cancer patients treated with anti-Her-2 therapy

Published:2016-12-23 Issue:3 Volume:8 Page:5219-5232
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Chen Tan-Huan¹²,Zhang Ying-Chun³,Tan Yu-Ting⁴,An Xin²,Xue Cong²,Deng Ying-Fei²,Yang Wei²,Yuan Xia¹,Shi Yan-Xia²

Affiliation:

1. Department of Medical Oncology, Affiliated Hui Zhou Municipal Central Hospital & Training Base for Masters of Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Huicheng District, Huizhou, Guangdong 516000, P. R. China

2. Department of Medical Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong 510000, P.R. China

3. Department of Pathology, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong 510000, P.R. China

4. Department of Radiotherapy, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong 510000, P.R. China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Link between the Polymorphisms of PIK3CA and p35 Genes and PARP Inhibitors' Prognosis in Breast Cancer;J BIOL REG HOMEOS AG;2023

2. Complexity and diversity of FOXP3 isoforms: Novel insights into the regulation of the immune response in metastatic breast cancer;International Immunopharmacology;2023-05

3. The prognostic values of FOXP3+ tumor-infiltrating T cells in breast cancer: a systematic review and meta-analysis;Clinical and Translational Oncology;2023-01-24

4. PREDICTIVE VALUE OF PDW AND PC ON THE PROGNOSIS OF PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER RECEIVING PLATINUM-CONTAINING CHEMOTHERAPY;ACTA MEDICA MEDITERR;2023

5. Development of Cancer Immunotherapies;Cancer Immunotherapies;2022